UNSPSC 51453500: Anthelmintic thiazoles

Anthelmintic drugs made from sulfur compounds with nitrogen, based on C3H3NS.

UNSPSC 51453500 Anthelmintic thiazoles is a Class code that shows minimal alignment between its nominal pharmaceutical scope and recent state and local procurement activity. The posted opportunities do not substantively address anthelmintic thiazole products; instead, state and local buyers have tagged pharmaceutical, medical supply, and pharmacy benefit management solicitations under this code in ways that diverge from the code's stated purpose. The actual work being bought includes naloxone and drug deactivation systems for emergency response, generic multi-source pharmaceuticals and OTC products for cooperative purchasing across state facilities, medical and first aid supplies for fire rescue operations, and direct-to-manufacturer prescription program capabilities for a state health and human services agency. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (Tampa), state health and human services commissions (Texas HHS), and multi-state cooperative purchasing alliances (Minnesota MMCAP).

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Representative solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding; the City of Tampa's IFB 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000.00; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) soliciting vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon. The code's tagging appears inconsistent with its intended pharmaceutical focus; business development professionals evaluating this code should verify the actual scope of work required before pursuing opportunities posted under it.